Schulte Roth & Zabel represented Deep Track Capital, while Crandon Law represented TORL BioTherapeutics in the transaction. TORL BioTherapeutics announced its closing of an oversubscribed $158 million Series...
Schulte Roth & Zabel represented Deep Track Capital, while Crandon Law represented TORL BioTherapeutics in the transaction. TORL BioTherapeutics announced its closing of an oversubscribed $158 million Series...
You must be a Standard 1 Year member to access this content.